Free Trial
NASDAQ:HRTS

Tema Cardiovascular and Metabolics ETF (HRTS) Price, Holdings, & News

Tema Cardiovascular and Metabolics ETF logo
$33.20
+0.57 (+1.75%)
(As of 11/1/2024 ET)

About Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS)

Key Stats

Today's Range
$32.80
$33.20
50-Day Range
$32.63
$35.34
52-Week Range
$26.26
$36.03
Volume
10,572 shs
Average Volume
24,060 shs
Market Capitalization
$82.34 million
Assets Under Management
$81.02 million
Dividend Yield
N/A
Net Expense Ratio
0.75%
Aggregate Rating
Moderate Buy

ETF Overview

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.

Tema Cardiovascular and Metabolics ETF Expenses

TypeHRTSTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.99%0.57%0.55%0.49%0.52%
Other Expenses0.00%0.57%0.49%0.41%0.53%
Total Expense0.99%0.73%0.71%0.63%0.71%
Fee Waiver-0.24%-0.74%-0.52%-0.32%-0.57%
Net Expense0.75%0.59%0.61%0.56%0.59%
Receive HRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE daily newsletter.

HRTS ETF News Headlines

HRT may help to protect the heart
Crypto Crash Ahead? (27 Experts Weigh In)
Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!
Oil Prices Spike Amid Middle East Tensions
Guardian Capital LP Launches Two New ETFs on CBOE Canada
See More Headlines

HRTS ETF - Frequently Asked Questions

Tema Cardiovascular and Metabolics ETF's stock was trading at $30.61 at the start of the year. Since then, HRTS shares have increased by 8.5% and is now trading at $33.20.
View the best growth stocks for 2024 here
.

Top institutional investors of Tema Cardiovascular and Metabolics ETF include Sterling Investment Advisors Ltd. (6.40%).

Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Cardiovascular and Metabolics ETF investors own include Scilex (SCLX), Rigetti Computing (RGTI), Pfizer (PFE), BlackBerry (BB), Butterfly Network (BFLY), BioNTech (BNTX) and Barrick Gold (GOLD).

Fund Details

Issuer
Tema Global
Fund Name
Tema Cardiovascular and Metabolics ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:HRTS
Inception Date
11/20/2023
Fund Manager
David Song, Yuri Khodjamirian
Previous Symbol
NASDAQ:HRTS
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
45

Fund Statistics

Assets Under Management
$81.02 million
Average Daily Volume
$0.00
Discount/Premium
-0.04%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Tema Global Limited
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bancorp Fund Services, LLC
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
10,800 shs

Miscellaneous

Beta
0.93
Creation Unit
10,000
Creation Fee
$500.00
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

Top 10 HRTS Holdings

HRTS Sector Exposure

HRTS Industry Exposure


This page (NASDAQ:HRTS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners